Retasturtide is a recently developed novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This artificial peptide duplicates the actions of naturally present GLP-1, a https://teganqbkn159195.ziblogs.com/39437148/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes